dc.contributor.author | Sleeman, Isobel | |
dc.contributor.author | Aspray, Terry | |
dc.contributor.author | Lawson, Rachael | |
dc.contributor.author | Coleman, Shirley | |
dc.contributor.author | Duncan, Gordon | |
dc.contributor.author | Khoo, Tien K | |
dc.contributor.author | Schoenmakers, Inez | |
dc.contributor.author | Rochester, Lynn | |
dc.contributor.author | Burn, David | |
dc.contributor.author | Yarnall, Alison | |
dc.date.accessioned | 2020-05-27T13:40:01Z | |
dc.date.available | 2020-05-27T13:40:01Z | |
dc.date.issued | 2017-11-01 | |
dc.identifier.citation | Sleeman , I , Aspray , T , Lawson , R , Coleman , S , Duncan , G , Khoo , T K , Schoenmakers , I , Rochester , L , Burn , D & Yarnall , A 2017 , ' The Role of Vitamin D in Disease Progression in Early Parkinson's Disease ' , Journal of Parkinson's Disease , vol. 7 , no. 4 , pp. 669-675 . https://doi.org/10.3233/JPD-171122 | en |
dc.identifier.issn | 1877-7171 | |
dc.identifier.other | PURE: 148740559 | |
dc.identifier.other | PURE UUID: 0028dc2c-ee6b-48a5-99b9-b22aa752edfb | |
dc.identifier.other | PubMed: 28984616 | |
dc.identifier.other | PubMedCentral: PMC5676984 | |
dc.identifier.other | Scopus: 85032828023 | |
dc.identifier.uri | https://hdl.handle.net/2164/14379 | |
dc.description | The authors acknowledge the study funders, Parkinson’s UK (J-0802), Newcastle University Lockhart Parkinson’s Disease fund and the Newcastle Biomedical Research Centre. The research was supported by the National Institute of Health Research (NIHR) Newcastle Biomedical Research Unit based at Newcastle upon Tyne Hospitals NHS Foundation Trust/Newcastle University. The research was also supported by NIHR Newcastle CRF Infrastructure funding. Newcastle University acknowledge the support of the NIHR, through the Dementias and Neurodegenerative Diseases Research Network. IS was supported by a NIHR clinical fellowship. The authors would like to thank Sarah Meadows and her colleagues Nutritional Biomarker Analysis laboratory at MRC Elsie Widdowson Laboratory for the analyses of 25 hydroxyvitamin D. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. | en |
dc.format.extent | 7 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Parkinson's Disease | en |
dc.rights | This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | balance | en |
dc.subject | cognition | en |
dc.subject | disease progression | en |
dc.subject | fall | en |
dc.subject | 25-hydroxy vitamin D | en |
dc.subject | Parkinson's disease | en |
dc.subject | vitamin D | en |
dc.subject | RA0421 Public health. Hygiene. Preventive Medicine | en |
dc.subject | Parkinson's UK | en |
dc.subject | J-0802 | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | RA0421 | en |
dc.title | The Role of Vitamin D in Disease Progression in Early Parkinson's Disease | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.3233/JPD-171122 | |
dc.identifier.vol | 7 | en |
dc.identifier.iss | 4 | en |